SABBY MANAGEMENT, LLC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 30 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2021$802,000
-13.9%
491,973
+68.5%
0.12%
-7.1%
Q3 2021$931,000
+7.8%
291,973
+66.9%
0.13%
+3.3%
Q2 2021$864,000
-88.6%
174,900
-81.0%
0.12%
-91.8%
Q1 2021$7,608,000922,1931.48%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q1 2022
NameSharesValueWeighting ↓
WealthTrust Axiom LLC 11,561$21,0000.01%
Tower Research Capital LLC (TRC) 38,887$73,0000.00%
Newbridge Financial Services Group, Inc. 312$1,0000.00%
Stonebridge Financial Planning Group, LLC 375$1,0000.00%
Squarepoint Ops LLC 15,680$29,0000.00%
OSAIC HOLDINGS, INC. 808$1,0000.00%
US BANCORP \DE\ 1,000$2,0000.00%
WELLS FARGO & COMPANY/MN 86$00.00%
NORTHERN TRUST CORP 16,192$30,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders